Can our experience with surveillance for inherited pancreatic cancer help to identify early pancreatic cancer in the general population?
Fam Cancer
; 23(3): 399-403, 2024 Aug.
Article
de En
| MEDLINE
| ID: mdl-38441833
ABSTRACT
Screening of the general population for cancer is a matter of primary prevention reducing the burden of disease. Whilst this is successful for several cancers including breast, colon and prostate, the situation to screen and hence prevent pancreatic cancer is different. The organ is not as accessible to simple physical exam or biological samples (fecal or blood test). Neither exists a blood test such as PSA that is cost-effective. Reviewing the evidence from screening risk groups for pancreatic cancer, one must conclude that there is no rational at present to screen the general population, for a lack of appropriate tests.
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Tumeurs du pancréas
/
Dépistage précoce du cancer
Limites:
Female
/
Humans
/
Male
Langue:
En
Journal:
Fam Cancer
/
Fam. cancer
/
Familial cancer
Sujet du journal:
NEOPLASIAS
Année:
2024
Type de document:
Article
Pays d'affiliation:
Suède
Pays de publication:
Pays-Bas